Search

shutterstock_2261453831(1) (1)

Announcements

Announcements

HOMEWhat’s NewAnnouncements

2017.Oct.20

Announcement on Change of the Accounting Officer

2017.Oct.06

USPTO Approved the Patent Application for OBI-888 "Antibodies, pharmaceutical compositions and uses thereof"

2017.Sep.25

Contract Signing with Pharmacore for the Contract Manufacturing of OBI-858

2017.Aug.11

Announcement on Change of the Acting Spokesperson

2017.Aug.11

Announcement on Change of the Head of Finance and Accounting

2017.Jul.21

OBI Received a Civil Complaint from Taiwan Shilin District Court

2017.Jul.12

Clarification on the news article by China Times

2017.Jun.29

Clarification on the news article by Commercial Times

2017.Jun.28

Important Resolutions of AGM 2017

2017.Jun.11

Supplemental information on the approved application of Phase III clinical trial of OBI-822, the novel breast cancer drug, in China, US, and the EU

News

Latest News

Events

Latest events